ARIAD Pharma (ARIA) Commences Common Offering
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Join SI Premium – FREE
ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) has commenced an underwritten public offering of shares of its common stock. All of the shares in the offering are to be sold by ARIAD.
J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the proposed offering. ARIAD intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the amount sold to cover over-allotments, if any. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan Securities LLC, Cowen and Company, LLC and Jefferies & Company, Inc. are acting as joint book-running managers and underwriters for the proposed offering. ARIAD intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the amount sold to cover over-allotments, if any. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Files for Share and Warrant Offering
- Centessa Pharmaceuticals (CNTA) Announces $100 Million Proposed Public Offering of American Depositary Shares
- Biodesix Inc. (BDSX) Files for 30.43M Share Offering by Selling Stockholders
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
JPMorgan, Jefferies & Co, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
